Reaction
Tongue Coated reporting signals
As of the last recalculation, Tongue Coated appears in 1,704 FAERS reports alongside 29 co-occurring drug terms. The strongest observed disproportionality signal is BIMEKIZUMAB (PRR 17.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bimekizumab | 30 | 17.5 | 17.5 |
| Metronidazole Topical | 60 | 15.9 | 15.9 |
| Metronidazole | 72 | 14.3 | 14.3 |
| Nitrofurantoin | 17 | 12.7 | 12.7 |
| Nitrofurantoin (Monohydrate/Macrocrystals) | 17 | 12.5 | 12.6 |
| Nystatin Ointment | 24 | 11.3 | 11.3 |
| Nystatin | 25 | 11.3 | 11.3 |
| Nystatin Cream | 24 | 11.3 | 11.3 |
| Fluticasone Furoate | 11 | 11.2 | 11.2 |
| Fosaprepitant Dimeglumine | 12 | 10.7 | 10.7 |
| Atovaquone | 7 | 10.7 | 10.7 |
| Gentamicin | 10 | 9.4 | 9.4 |
| Desoximetasone | 14 | 9.0 | 9.0 |
| Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate | 30 | 9.0 | 9.0 |
| Nirmatrelvir And Ritonavir | 39 | 9.0 | 9.0 |
| Aprepitant | 12 | 8.0 | 8.0 |
| Pertuzumab | 17 | 7.7 | 7.7 |
| Fluticasone Propionate And Salmeterol | 24 | 7.1 | 7.1 |
| Fluticasone Furoate And Vilanterol Trifenatate | 20 | 6.9 | 6.9 |
| Umeclidinium Bromide And Vilanterol Trifenatate | 9 | 6.6 | 6.6 |
| Cortisone Acetate | 6 | 6.0 | 6.0 |
| Rucaparib | 4 | 5.5 | 5.5 |
| Nintedanib | 14 | 5.5 | 5.5 |
| Docetaxel Anhydrous | 24 | 4.4 | 4.4 |
| Docetaxel | 24 | 4.4 | 4.4 |
| Cenobamate | 3 | 4.4 | 4.4 |
| Pegfilgrastim | 28 | 3.5 | 3.5 |
| Cabozantinib | 13 | 3.3 | 3.3 |
| Varenicline Tartrate | 21 | 3.2 | 3.2 |